Literature DB >> 15825530

Effect of the menstrual cycle on standard achromatic and blue-on-yellow visual field analysis of women with migraine.

Iclal Yucel1, Munire Erman Akar, Babur Dora, Yusuf Akar, Omur Taskin, Hilmi O Ozer.   

Abstract

BACKGROUND: It has been postulated that migraine and glaucoma may have common vascular causative factors. Significant sex-based differences in the incidence of many important ocular conditions raise the possibility that estrogens may have direct effects on the eye. We performed a study to determine the effect of the menstrual cycle on standard achromatic automated perimetry (SAP) and short-wavelength automated perimetry (SWAP) (blue-on-yellow perimetry) of women with migraine.
METHODS: Both eyes of 73 normally menstruating women (31 subjects with migraine and 42 healthy control subjects) were included in the study. Subjects underwent a complete ocular examination including SAP and SWAP in both the follicular phase (12th to 13th day of the cycle) and the luteal phase (1 to 2 days before the onset of bleeding) of two consecutive menstrual cycles.We performed visual field analysis using the Humphrey Field Analyzer II with the full-threshold central 30-2 program. Mean sensitivity was calculated for the superior temporal, inferior temporal, superior nasal and inferior nasal regions separately.
RESULTS: Thirteen subjects were lost to follow-up (5 in the migraine group and 8 in the control group), leaving 26 subjects and 34 subjects respectively. There was no significant difference in mean age between the two groups (33.9 years [standard deviation (SD) 3.4 years] vs. 35.1 years [SD 3.3 years]). The mean duration of migraine was 7.6 (SD 3.1) years (range 3-14 years). In both groups, serum estradiol levels were significantly lower (p = 0.001) and serum progesterone levels were significantly higher (p < 0.001) in the luteal phase than in the follicular phase. In the control group, the mean sensitivity values with SWAP were significantly lower in the luteal phase than in the follicular phase (p = 0.04). A similar decrease was observed for the subjects with migraine with both SAP and SWAP (p = 0.01). There was no difference in regional mean sensitivity between the two phases with either perimetric test in the control group. For the subjects with migraine, there was no difference in regional mean sensitivity between the two phases with SAP. However, with SWAP, the mean sensitivity for the nasal visual field locations was significantly lower in the luteal phase than in the follicular phase (p = 0.01).
INTERPRETATION: Our study provides further evidence of an effect of sex hormones on the visual field of women with migraine. In addition to assessment of intraocular pressure, menstrual cycle phases should be considered in women with migraine at risk for glaucomatous optic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15825530     DOI: 10.1016/S0008-4182(05)80117-6

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  7 in total

1.  Progesterone treatment in two rat models of ocular ischemia.

Authors:  Rachael S Allen; Timothy W Olsen; Iqbal Sayeed; Heather A Cale; Katherine C Morrison; Yuliya Oumarbaeva; Irina Lucaciu; Jeffrey H Boatright; Machelle T Pardue; Donald G Stein
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

Review 2.  Is Estrogen a Therapeutic Target for Glaucoma?

Authors:  Samantha S Dewundara; Janey L Wiggs; David A Sullivan; Louis R Pasquale
Journal:  Semin Ophthalmol       Date:  2016       Impact factor: 1.975

Review 3.  Neuroprotective strategies for retinal disease.

Authors:  Machelle T Pardue; Rachael S Allen
Journal:  Prog Retin Eye Res       Date:  2018-02-23       Impact factor: 21.198

4.  Anterior Segment Findings in Women with Polycystic Ovary Syndrome.

Authors:  Seda Karaca Adıyeke; Ibrahim Karaca; Suna Yıldırım; Mehmet Adıyeke; İbrahim Uyar; Gamze Türe
Journal:  Turk J Ophthalmol       Date:  2017-01-17

5.  Identification of Estrogen Signaling in a Prioritization Study of Intraocular Pressure-Associated Genes.

Authors:  Hannah A Youngblood; Emily Parker; Jingwen Cai; Kristin Perkumas; Hongfang Yu; Jason Sun; Sylvia B Smith; Kathryn E Bollinger; Janey L Wiggs; Louis R Pasquale; Michael A Hauser; W Daniel Stamer; Yutao Liu
Journal:  Int J Mol Sci       Date:  2021-09-24       Impact factor: 6.208

6.  Visual field fluctuations correlating with the menstrual cycle in a patient with optic pathway glioma.

Authors:  Adam Jacobson; Marcia Leonard; Patricia Robertson; Brenda L Bohnsack
Journal:  BMJ Case Rep       Date:  2020-04-07

7.  Estrogen pathway polymorphisms in relation to primary open angle glaucoma: an analysis accounting for gender from the United States.

Authors:  Louis R Pasquale; Stephanie J Loomis; Robert N Weinreb; Jae H Kang; Brian L Yaspan; Jessica Cooke Bailey; Douglas Gaasterland; Terry Gaasterland; Richard K Lee; William K Scott; Paul R Lichter; Donald L Budenz; Yutao Liu; Tony Realini; David S Friedman; Catherine A McCarty; Sayoko E Moroi; Lana Olson; Joel S Schuman; Kuldev Singh; Douglas Vollrath; Gadi Wollstein; Donald J Zack; Murray Brilliant; Arthur J Sit; William G Christen; John Fingert; Peter Kraft; Kang Zhang; R Rand Allingham; Margaret A Pericak-Vance; Julia E Richards; Michael A Hauser; Jonathan L Haines; Janey L Wiggs
Journal:  Mol Vis       Date:  2013-07-12       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.